TABLE 1.
The demographic and descriptive variables of the patients (n = 388) and the statistical assessment according to mortality
| Variables | Total patients (n = 388) | Mortality (+) (n = 13) | Mortality (−) (n = 375) | P |
|---|---|---|---|---|
| Age (years, mean ± SD) | 60.9 ± 12.9 | 74.8 ± 6.7 | 60.4 ± 12.8 | <.001 |
| Sex (Male) [n (%)] | 260 (67) | 8 (61.5) | 252 (67.2) | .341 |
| APACHE II (mean ± SD) | 7.9 ± 3.5 | 14.3 ± 6.5 | 7.7 ± 3.1 | <.001 |
| Charlson comorbidity index(mean ± SD) | 5.7 ± 2.9 | 8.5 ± 3.9 | 5.6 ± 2.8 | .005 |
| Location of the tumor | .950 | |||
| Right Colon [n (%)] | 205 (52.8) | 6 (46.2) | 199 (53.1) | |
| Left colon [n (%)] | 89 (22.9) | 5 (38.5) | 84 (22.4) | |
| Rectum [n (%)] | 94 (24.2) | 2 (15.4) | 92 (24.5) | |
| Histological grade | .454 | |||
| Well‐differentiated [n (%)] | 98(25.3) | 2(15.5) | 96(25.6) | |
| Moderate differentiated [n (%)] | 198(51) | 7 (53.8) | 191(50.9) | |
| Poorly differentiated [n (%)] | 92(23.7) | 4(30.7) | 88(23.5) | |
| TNM stage | .267 | |||
| Stage I [n (%)] | 64(16.5) | 3(23) | 61(16.3) | |
| Stage II [n (%)] | 124 (32) | 2(15.4) | 122(32.5) | |
| Stage III [n (%)] | 136(35) | 6(46.2) | 130(34.7) | |
| Stage IV [n (%)] | 64(16.5) | 2(15.4) | 62(16.5) | |
| Metastasis [n (%)] | 68 (17.5) | 3 (23.1) | 65 (17.3) | .593 |
Note: P‐value was determined with either Spearman Rho or Mann‐Whitney U test.
Abbreviations: APACHE II, Acute Physiologic Assessment and Chronic Health Evaluation II; SD, standard deviation; TNM stage, clinical tumor‐node‐metastasis stage.